Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2006
05/09/2006US7041465 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
05/09/2006US7041464 Method for determining a gushing factor for a beverage
05/09/2006US7041463 Orthologues of human receptors and methods of use
05/09/2006US7041462 analyzing a non-denatured protein by high pressure liquid chromatography; by using chimeric genes replacing a native signal sequence with a different signal sequence resulting in the production of a conformer, one can compare the native protein with the product of the chimeric gene
05/09/2006US7041461 Nucleotide sequences coding membrame protein for use in analgesics
05/09/2006US7041460 Antibodies to monocyte-colony inhibitory factor (M-CIF)
05/09/2006US7041459 Analyzing phosphorylated proteins
05/09/2006US7041458 Methods and reagents for determining protein S
05/09/2006US7041457 G-protein receptor for use in the detection of modulators of taste, odor and attraction
05/09/2006US7041455 Method and apparatus for pattern identification in diploid DNA sequence data
05/09/2006US7041453 Chimeric peptide nucleic acid for diagnosis, prevention and treatment of neurodegenerative, blood, muscular, cardiovascular, glandular and gastrointestinal disorders; rational drug design and screening
05/09/2006US7041451 Electrochemiluminescence helicase assay
05/09/2006US7041449 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging
05/09/2006US7041445 Long oligonucleotide arrays
05/09/2006US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects
05/09/2006US7041441 Phage display of intact domains at high copy number
05/09/2006US7041439 Methods and apparatus for selectively processing eggs having identified characteristics
05/09/2006US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions.
05/09/2006US7041371 polyethylene glycol of a number average molecular weight of 1000-7000 having a thiol group at one end, bonded directly via cadmium to II VI semiconductor nanocrystals of a core-shell structure having a ZnX shell, wherein X stands for O, S, Se, or Te; the nanoparticles are water soluble
05/09/2006US7041362 Methods for identification and verification
05/09/2006US7041298 Regulating protein activity with an ubiquitin pathway protein binding moiety coupled to a targeting moiety; used to perform target ubiquitination
05/09/2006US7041297 Tumor antigen peptides originating in cyclophilin B
05/09/2006US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/09/2006US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury
05/09/2006US7041276 Administering the agent to a teleost and detecting a response in the teleost indicating angiogenesis activity
05/09/2006US7041256 Poison resistant combustible gas sensors and method for warning of poisoning
05/09/2006US7041254 Kit for measuring analytes
05/09/2006US7041253 Sample collection and test device
05/09/2006US7041235 Fluorescent diketopyrrolopyrrole analogues
05/09/2006US7041206 Medical diagnostic system
05/09/2006US7041068 Sampling module device and method
05/09/2006US7041057 Tissue interface device
05/09/2006US7040804 Method for measuring diffusion coefficient in conductive melts, and apparatus for measuring the same
05/09/2006US7040529 Drop box for isolating received items
05/09/2006US7040183 Arrangement for passive gas sampling
05/09/2006US7040157 Variable depth automated dynamic water profiler
05/09/2006US7040156 Flexible membrane encapsulated strain measurement instrument and method of manufacture
05/09/2006US7040145 Method and apparatus for measuring dry density and water content of soil
05/09/2006US7040139 Sensor arrangement
05/09/2006US7040138 Method and device for the monitoring of gases
05/09/2006CA2306853C Method and apparatus for measuring lipid peroxidation in biological fluids and suspensions of tissues
05/09/2006CA2270222C A method and flow system for spectrometry and a cuvette for the flow system
05/09/2006CA2264839C Sensors for detecting analytes in fluids
05/09/2006CA2262668C Inhibitors of cathepsin k
05/09/2006CA2261081C Sensor for evaluating dielectric properties of specialized paper
05/09/2006CA2247094C A method for analyzing characteristics of a moving object, such as a log
05/09/2006CA2228246C Control of batching and curing processes
05/09/2006CA2167109C Dispensing instrument for fluid monitoring sensors
05/09/2006CA2136148C Liquid separation apparatus and method
05/09/2006CA2117913C Activation-state-specific phosphoprotein immunodetection
05/04/2006WO2006047760A1 Real-time assessment of biomarkers for disease
05/04/2006WO2006047670A2 Methods for assessing antibodies to neurodegenerative disease-associated antigens
05/04/2006WO2006047662A2 Method and apparatus for sediment characterization
05/04/2006WO2006047475A2 Detection and analysis of ophthalmically-relevant fluorescent molecules
05/04/2006WO2006047471A2 A method of nucleic acid typing for selecting registered donors for cross-matching to transfusion recipients
05/04/2006WO2006047452A2 Reactive 1,3’-crosslinked carbocyanines and their bioconjugates
05/04/2006WO2006047451A2 Immunoassays for lamotrigine
05/04/2006WO2006047450A2 Immunoassays for topiramate
05/04/2006WO2006047372A2 Lamotrigine analogs
05/04/2006WO2006047315A2 Targeted delivery of biological factors using self-assembling peptide nanofibers
05/04/2006WO2006047298A2 Eph receptor tumor biomarkers
05/04/2006WO2006047254A1 Assemblies of oligomeric amyloid beta protein and uses thereof
05/04/2006WO2006047242A2 Duffy antigen receptor for chemokines and use thereof
05/04/2006WO2006047204A1 Topiramate analogs
05/04/2006WO2006047172A1 Tweak receptor
05/04/2006WO2006047135A1 Sensor-dispensing device and mechanism for extracting sensor
05/04/2006WO2006047125A2 Method for immobilizing molecular probes to a semiconductor oxide surface
05/04/2006WO2006047038A1 Apparatus and method for cell migration assays
05/04/2006WO2006046997A2 Process, system and method for improving the determination of digestive effects upon an ingestable substance
05/04/2006WO2006046990A1 Detection of trichomonas
05/04/2006WO2006046988A1 Phased vii micro fluid analyzer having a modular structure
05/04/2006WO2006046964A2 High-temperature gas sensors and their use in exhaust gases
05/04/2006WO2006046867A1 Method for accelerated measurement of fading characteristics of recording media, as well as recording media
05/04/2006WO2006046716A1 Reaction vessel
05/04/2006WO2006046693A1 Method of assyaing htlv-i-specific t cell response
05/04/2006WO2006046644A1 Method of examining alzheimer’s disease and diagnostic reagent
05/04/2006WO2006046588A1 Disease diagnosing system
05/04/2006WO2006046538A1 Method of determining level of specified component in blood sample and apparatus for level determination
05/04/2006WO2006046509A1 Cantilever sensor, sensor system and method of detecting analyte in specimen liquid
05/04/2006WO2006046492A1 Novel ppar regulating agent and method of screening the same
05/04/2006WO2006046433A1 Microreactor for genetic test
05/04/2006WO2006046229A2 A detector comprising a membrane perturbation - detecting polymer and functional membrane fragments
05/04/2006WO2006046136A1 Optical transparent sensor for detecting sulphur dioxide (so2) in a gaseous sample
05/04/2006WO2006046134A2 Method of screening by using conformation sensitive peptides
05/04/2006WO2006046076A2 Applications of isolated nucleic acid fragments comprising cpg islands
05/04/2006WO2006046073A2 C1q related protein
05/04/2006WO2006046054A1 Assay system
05/04/2006WO2006046026A1 Methods and means
05/04/2006WO2006045939A1 Modulating synaptic transmission by semaphorins and applications thereof
05/04/2006WO2006045827A1 Identification of a jak2 mutation in polycythemia vera
05/04/2006WO2006045799A2 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
05/04/2006WO2006045628A1 Adsorption monitoring device
05/04/2006WO2006045596A1 Multifunctional reference system for use in analyte detection by fluorescence
05/04/2006WO2006045593A1 Plgf and flt-1 as prognostic parameters for cardiovascular diseases
05/04/2006WO2006045558A1 Surface preparation method
05/04/2006WO2006045476A2 Gpr17 modulators, method of screening and uses thereof
05/04/2006WO2006045308A2 Chlamydia trachomatis antigens for vaccine and diagnostic use
05/04/2006WO2006032926A9 Improvements in high content screening
05/04/2006WO2006030232A3 Monitoring of wounds by measurement of protease and protease inhibitor levels in wound fluids
05/04/2006WO2006030219A3 Assay method